1301/2682US=23 / Câncer
Benson JR, Turner EH, Winters Z. Breast cancer: side effects of tamoxifen and anastrozole. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 433-57. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TAMOXIFENO; ANASTROZOL; TERAPIA ANTI-HORMONAL; CANCER DE MAMA AVANCADO; TERAPIA HORMONAL NEOADJUVANTE; TERAPIA HORMONAL ADJUVANTE; QUIMIOPREVENCAO; INIBIDORES DE AROMATASE


1302/2682US=23 / Câncer
Shackney SE, Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA. Breast cancer: expression of HER-2 and epidermal growth factor receptor as clinical markers for response to targeted therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 459-82. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; EXPRESSAO DO RECEPTOR HER-2; FATOR DE CRESCIMENTO EPIDERMICO; RESPOSTA A TERAPIA-ALVO; IMUNOHISTOQUIMICA; HIBRIDACAO IN SITU FLUORESCENTE


1303/2682US=23 / Câncer
Bafford AC, Garber JE, Chittenden A, Golshan M. Young breast cancer patients undergoing breast-conserving therapy: role of BRCA1 and BRCA2. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 483-91. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; PACIENTES JOVENS; TERAPIA CONSERVADORA DA MAMA; BRCA1; BRCA2


1304/2682US=35 / Biol/Mol
Bafico A, Grumolato L, Aaronson SA. Oncogenes and signal transduction. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 17-30. ISBN 978-1-4160-3703-3.

ONCOGENE; TRANSDUCAO DE SINAL; RECEPTORES DE TIROSINA-QUINASE; RECEPTORES DE CITOCINA; NEUROTRANSMISSORES; SINALIZACAO WNT; TERAPIA DO CANCER


1305/2682US=2 / Tórax
McWilliams A. Treatment of preneoplastic lesions of the lung. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 111-20. ISBN 978-1-4051-5112-2.

LESOES PRE-NEOPLASICAS DO PULMAO. TRATAMENTO; NEOPLASIA INTRAEPITELIAL; TERAPIAS ENDOBRONQUICAS; TERAPIA FOTODINAMICA; ELETROCAUTERIO ENDOBRONQUICA; CRIOTERAPIA; BRAQUITERAPIA


1306/2682US=35 / Biol/Mol
Mendelsohn J, Powis G. From bench to bedside with targeted therapies. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 521-30. ISBN 978-1-4160-3703-3.

TERAPIA ALVO MOLECULAR; MEDICINA PERSONALIZADA


1307/2682US=35 / Biol/Mol
Shoemaker RH, Sausville EA. Screening strategies for targeted therapeutics. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 531-8. ISBN 978-1-4160-3703-3.

TRIAGEM; TERAPIAS-ALVO; CANCER. TERAPIA


1308/2682US=35 / Biol/Mol
Morton CL, Houghton PJ. Animal models to predict anticancer efficacy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 539-45. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; EXPERIMENTOS


1309/2682US=35 / Biol/Mol
Hait WN, Rubin E, Bertino JR. Cancer therapeutics. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 571-81. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; TERAPEUTICOS; INDICE TERAPEUTICO; DROGAS


1310/2682US=35 / Biol/Mol
Sikic BI. Natural and acquired resistance to cancer therapies. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 583-92. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; RESISTENCIA NATURAL; RESISTENCIA ADQUIRIDA; FALHA NO TRATAMENTO; RESISTENCIA A DROGAS


1311/2682US=35 / Biol/Mol
Woodward WA, Cox JD. Molecular basis of radiation therapy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 593-604. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; RADIOTERAPIA; MORTE CELULAR; RADIOBIOLOGIA TRANSLATIONAL


1312/2682US=35 / Biol/Mol
Posada JG Jr, Frankel AE. Monoclonal antibody therapy of cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 671-8. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; ANTICORPOS MONOCLONAIS


1313/2682US=35 / Biol/Mol
McCormick F, Korn WM. Gene therapy and oncolytic viruses. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 679-90. ISBN 978-1-4160-3703-3.

VIRUS ONCOLITICOS; TERAPIA GENETICA; MORTE DAS CELULAS CANCERIGENAS


1314/2682US=35 / Biol/Mol
Neckers L. Heat shock protein 90 and the proteasome: housekeeping proteins become novel molecular targets for cancer therapy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 701-10. ISBN 978-1-4160-3703-3.

PROTEINA DE CHOQUE TERMICO 90; PROTEASSOMA; ALVOS MOLECULARES; CANCER. TERAPIA; HSP90


1315/2682US=23-A / Câncer
Kettunen MI, Grohn OHJ. Tumor gene therapy: magnetic resonance imaging and magnetic resonance spectroscopy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 39-53. ISBN 978-1-4020-8441-62.

CANCER; TERAPIA GENETICA; RESSONANCIA MAGNETICA; ESPECTROSCOPIA


1316/2682US=2 / Tórax
Chang JY, Smith AR, Cox JD. Proton therapy. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 271-82. ISBN 978-1-4051-5112-2.

PROTON TERAPIA; PROTONS. TRATAMENTO; MOVIMENTO TUMOR


1317/2682US=2 / Tórax
Huynh M, Lara PN Jr. Proteasome inhibition in nonsmall cell lung cancer therapy. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 400-10. ISBN 978-1-4051-5112-2.

INIBICAO DO PROTEASSOMA EM NAO PEQUENA; TERAPIA DE CANCER DE PULMAO DE CELULAS


1318/2682US=23-A / Câncer
Crook J. Locally advanced protate cancer biochemical recurrence after radiotherapy: use of cyclic androgen withdrawal therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 565-77. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; RECORRENCIA LOCALMENTE AVANCADO; BIOQUIMICA; RADIOTERAPIA; TERAPIA CICLICA; ANDROGENO


1319/2682US=2 / Tórax
Roth JA. Targeted genetic therapy for lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 411-20. ISBN 978-1-4051-5112-2.

TERAPIA GENETICA; CANCER DE PULMAO. TERAPIA


1320/2682US=23-B / Câncer
Bowen KA, Riall TS. Periampullary adenocarcinoma: diagnosis and survival after pancreaticoduodenectomy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 211-26. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; ADENOCARCINOMA PERIAMPOLAR; PANCREATODUODENECTOMIA; FATORES DE RISCO; DIAGNOSTICO; ESTADIAMENTO; TERAPIA ADJUVANTE; TERAPIA NEOADJUVANTE


Primeira | Anterior | Próxima | Última